1. Israel Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
BATM Advanced Communications Ltd.

BATM Advanced Communications Ltd.

BVC.TA
BATM Advanced Communications Ltd.IL flagTel Aviv Stock Exchange
49.50
ILA
-0.40
- -
216.25MMarket Cap
BATM Advanced Communications Ltd.
BVC.TA
(Tel Aviv Stock Exchange)

Recent

price

49.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.3
0.27
0.28
0.28
0.27
0.24
0.22
0.27
0.3
0.29
0.42
0.32
0.26
0.26
0.27
- -
Revenue per Share
- -
-0.01
- -
-0.01
-0.01
-0.03
- -
- -
- -
0.01
0.02
0.03
- -
- -
-0.05
- -
Basic EPS, GAAP
0.02
- -
- -
- -
-0.02
-0.02
-0.01
-0.01
- -
0.01
0.03
0.01
-0.02
- -
-0.01
- -
Free Cash Flow per Basic Share
0.02
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
Dividend per Share
- -
-0.71
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.23
0.21
0.22
0.22
0.21
0.16
0.15
0.16
0.15
0.19
0.22
0.25
0.22
0.22
0.19
- -
Tangible Book Value per Share
402
403
403
403
403
403
403
403
403
421
440
440
440
441
441
- -
Basic Weighted Avg Shares
121
111
114
114
109
97
90
107
120
123
184
140
116
117
117
- -
Sales/Revenue/Turnover
-0.02
-1.85
-0.99
-4.76
-2.5
-1.2
-4.76
-1.27
-0.21
-1.67
7.43
8.1
0.44
2.27
1.61
- -
Operating Margin (%)
6
6
5
5
4
3
3
3
3
5
5
5
5
5
5
- -
Depreciation Expense
2
-4
1
-5
-3
-13
-1
- -
- -
4
10
14
- -
- -
-22
- -
Net Income, GAAP
81.16
- -
247.24
- -
- -
- -
- -
61.98
51.57
9.94
7.84
37.45
17.89
27.99
- -
- -
Effective Tax Rate (%)
1.41
-3.36
0.63
-3.95
-2.91
-13.65
-1.18
0.22
0.3
3.17
5.33
10.24
0.21
-0.17
-19
- -
Profit Margin (%)
73
62
65
62
55
47
45
49
43
58
64
76
64
63
52
- -
Working Capital
10
6
1
2
1
3
1
1
- -
9
9
6
6
4
2
- -
LT Debt
123
110
110
107
99
80
81
86
83
104
119
124
114
119
93
- -
Total Equity
- -
- -
1.4
- -
- -
- -
- -
-0.56
-0.13
-1.74
9.43
4.94
0.31
1.51
- -
- -
Return on Invested Capital (%)
17.22
- -
-0.63
- -
- -
- -
- -
21.58
41.93
66.2
64.44
128.42
7.68
7.52
- -
- -
Return on Capital (%)
139.86
- -
- -
-371.29
-261.18
-1,089.64
-87.99
19.16
29.43
308.79
741.89
1,086.36
18.48
-14.62
-1,689.09
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
117
2024
- -
- -
- -
- -
117
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.05
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Poly Medicure Limited (POLYMED.NS)
JINS HOLDINGS Inc. (JNDOF)
Innovative Eyewear, Inc. (LUCY)
Prim, S.A. (PRM.MC)
Guangzhou LBP Medicine Science & Technology Co., Ltd. (688393.SS)
Becton, Dickinson and Company (BDXB)
Business
BATM Advanced Communications Ltd. develops, produces and markets real-time technologies for networking, cybersecurity and biomedical applications; core offerings span carrier-grade network edge demarcation and aggregation platforms including edge-to-cloud solutions for telecom operators; advanced Carrier Ethernet Layer 2 encryption products powered by post-quantum cryptography and quantum key distribution for securing data-in-transit in mission-critical enterprise and infrastructure applications; IP surveillance and software services such as training and technical support; and diagnostic laboratory equipment focused on molecular diagnostics, infectious diseases, in-vitro reagents and instruments, alongside non-core biological pathogenic waste treatment solutions for medical, agricultural and pharmaceutical sectors. The company, founded in 1992 and headquartered in Hod Hasharon, Israel, with offices in North America, Europe and the Far East, targets telecom service providers, Tier 1 businesses, governments and emerging markets in Eastern Europe and Asia through its Networking & Cyber and Diagnostics divisions. In 2025, BATM executes a strategic refocus by divesting non-core assets including the sale of its 51% stake in Progenetics Ltd for $2 million cash expected in H1 2025, the agreement to sell Romanian diagnostics distributor A.M.S 2000 Trading Impex SRL for £17.6 million in shares pending shareholder approval, and preparations to divest its eco-med business, alongside reporting revenue growth in Cyber and Diagnostics divisions despite overall net loss anticipation from impairments.